Counterfeit and substandard quality of drugs: The need for an effective and stringent regulatory control in India and other developing countries

Azhar Khan, Naushad Ghilzai

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalIndian Journal of Pharmacology
Volume39
StatePublished - Jan 1 2007

Keywords

  • India
  • article
  • developing country
  • drug control
  • drug cost
  • drug industry
  • drug labeling
  • drug marketing
  • drug quality
  • drug stability
  • drug storage
  • drug treatment failure
  • fansidar
  • generic drug
  • government regulation
  • law enforcement
  • medicolegal aspect
  • physical chemistry
  • quality control
  • standard
  • tuberculostatic agent
  • vaccine
  • world health organization

Disciplines

  • Pharmacy and Pharmaceutical Sciences

Cite this